NuCana plc ADR (NCNA)
Market Closed
12 Dec, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
3. 79
-0.26
-6.42%
$
24.11M Market Cap
- P/E Ratio
- Div Yield
66,341 Volume
-15.75 Eps
$ 4.05
Previous Close Day Range
3.74 4.09
Year Range
2.78 330
Want to track NCNA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Baillie Gifford's Strategic Acquisition of NuCana PLC Shares
On September 1, 2024, Baillie Gifford (Trades, Portfolio), a prominent investment management firm, expanded its portfolio by acquiring 917,600 shares of NuCana PLC, a UK-based biopharmaceutical company. This transaction, executed at a price of $3.66 per share, marks a significant addition to Baillie Gifford (Trades, Portfolio)'s holdings, reflecting a strategic move within the biotechnology sector.
Gurufocus | 1 year ago
NuCana Stock Soars 151% on Upbeat Efficacy Data From Melanoma Study
NCNA stock surges 151% on positive efficacy data from the mid-stage melanoma study of NUC-7738 in combination with Merck's Keytruda.
Zacks | 1 year ago
2025 © Marketlog. All Rights Reserved.
